Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

PROCEPT BioRobotics (PRCT) EBIT (2020 - 2025)

Historic EBIT for PROCEPT BioRobotics (PRCT) over the last 6 years, with Q3 2025 value amounting to -$23.2 million.

  • PROCEPT BioRobotics' EBIT fell 341.11% to -$23.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$92.5 million, marking a year-over-year increase of 1308.65%. This contributed to the annual value of -$96.6 million for FY2024, which is 1150.13% up from last year.
  • Per PROCEPT BioRobotics' latest filing, its EBIT stood at -$23.2 million for Q3 2025, which was down 341.11% from -$22.2 million recorded in Q2 2025.
  • In the past 5 years, PROCEPT BioRobotics' EBIT ranged from a high of -$11.3 million in Q1 2021 and a low of -$29.6 million during Q4 2023
  • Moreover, its 5-year median value for EBIT was -$22.4 million (2024), whereas its average is -$21.8 million.
  • Its EBIT has fluctuated over the past 5 years, first plummeted by 8069.92% in 2023, then skyrocketed by 3331.53% in 2024.
  • PROCEPT BioRobotics' EBIT (Quarter) stood at -$16.8 million in 2021, then plummeted by 48.77% to -$25.0 million in 2022, then decreased by 18.04% to -$29.6 million in 2023, then skyrocketed by 33.32% to -$19.7 million in 2024, then fell by 17.67% to -$23.2 million in 2025.
  • Its last three reported values are -$23.2 million in Q3 2025, -$22.2 million for Q2 2025, and -$27.4 million during Q1 2025.